Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine + Cisplatin/Carboplatin in Salivary Gland Tumors
NCT00079079Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Oct 2003
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in Malignant salivary gland tumor (SGC), sponsored by Canadian Cancer Trials Group. Started Oct 2003; status: completed.
02
Drugs
gemcitabine
03
Conditions
Malignant salivary gland tumor (SGC)
Beyond the preview
Go deeper on NCT00079079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079079.